← Leaderboards
Michael H Cardone
Merrimack Pharmaceuticals, Inc.
$5,602,387
Attributed
$5,602,387
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,602,387 · 5
By mechanism
R44$4,975,544 · 2
R43$426,983 · 2
N43$199,860 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaMultiple MyelomaBaseDiagnostic TestsClinical TrialsPharmaceutical PreparationsCancer CellCellsMalignant NeoplasmsIn VitroPharmacologic SubstanceTumorHematologic NeoplasmsReportingCancer TherapyOralSmall MoleculeAnalogFamilyDrug Delivery SystemsDiagnosticDrug KineticsCompanionsComputer Simulation
Grant awards (9)
Commercializing Praedicare Dx TM platform for guiding cancer treatments$1,000,000
R44 · FY2019 · CA · contact PI
Commercializing Praedicare Dx TM platform for guiding cancer treatments$991,179
R44 · FY2018 · CA · contact PI
Commercializing Praedicare Dx TM platform for guiding cancer treatments$998,807
R44 · FY2017 · CA · contact PI
Development of small molecule inhibitor of Mcl-1 for cancer treatment$971,831
R44 · FY2011 · CA · contact PI
Development of small molecule inhibitor of Mcl-1 for cancer treatment$321,958
R44 · FY2011 · CA · contact PI
Development of small molecule inhibitor of Mcl-1 for cancer treatment$691,769
R44 · FY2010 · CA · contact PI
BH3 Profiling as a Companion Diagnostic For Velcade$199,860
N43 · FY2010 · CA · contact PI
Development of small molecule inhibitors of Mcl-1 for cancer treament$326,983
R43 · FY2008 · CA · contact PI
Protein Microarrays in Cancer Drug Discovery$100,000
R43 · FY2004 · CA